CHC
ORMP icon

City Holding Co’s Oramed Pharmaceuticals ORMP Stock Holding History

City Holding Co’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,070
Closed -$2.61K – 474
2024
Q3 		$2.61K Hold
1,070
– – ﹤0.01% 439
2024
Q2 		$2.74K Hold
1,070
– – ﹤0.01% 438
2024
Q1 		$3.12K Hold
1,070
– – ﹤0.01% 454
2023
Q4 		$2.46K Hold
1,070
– – ﹤0.01% 459
2023
Q3 		$2.78K Hold
1,070
– – ﹤0.01% 466
2023
Q2 		$3.82K Hold
1,070
– – ﹤0.01% 464
2023
Q1 		$2.33K Hold
1,070
– – ﹤0.01% 488
2022
Q4 		$12.9K Hold
1,070
– – ﹤0.01% 412
2022
Q3 		$7K Hold
1,070
– – ﹤0.01% 454
2022
Q2 		$5K Hold
1,070
– – ﹤0.01% 463
2022
Q1 		$9K Hold
1,070
– – ﹤0.01% 443
2021
Q4 		$11K Hold
1,070
– – ﹤0.01% 433
2021
Q3 		$24K Hold
1,070
– – ﹤0.01% 371
2021
Q2 		$14K Buy
+1,070
New +$12.2K ﹤0.01% 417

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

City Holding Co's ORMP Position: Q4 2024 in Review

City Holding Co sold out of Oramed Pharmaceuticals (ORMP) in Q4 2024, closing a stake of 1,070 shares — an estimated $2.61K sold.

City Holding Co first reported a position in ORMP in Q2 2021 and held it in 14 quarters. The position peaked at $24K in Q3 2021. 56 funds tracked by Wall St. Rank hold ORMP as of Q4 2024.

  • City Holding Co reported no remaining Oramed Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • City Holding Co sold 1,070 Oramed Pharmaceuticals shares in Q4 2024, an estimated $2.61K.
  • City Holding Co first reported a position in Oramed Pharmaceuticals in Q2 2021 and held it in 14 quarters.
  • City Holding Co's Oramed Pharmaceuticals position peaked at $24K in Q3 2021.
  • 56 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q4 2024.

Based on City Holding Co's 13F filing for Q4 2024, filed 16 Jan 2025.